Antitumor activity of YM155, a selective survivin suppressant, in combination with cisplatin in hepatoblastoma

Author：

E-ISSN： 1791-2431|34|1|407-414

ISSN： 1021-335X

Source： Oncology Reports, Vol.34, Iss.1, 2015-01, pp. : 407-414

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Antitumor effect of YM155, a novel small-molecule survivin suppressant, via mitochondrial apoptosis in human MFH/UPS

International Journal of Oncology, Vol. 47, Iss. 3, 2015-01 ,pp. : 891-899

Spandidos Publications

Access to resources Recommend Favorite

Knockdown of survivin contributes to antitumor activity in cisplatin-resistant ovarian cancer cells

Molecular Medicine Reports, Vol. 7, Iss. 2, 2013-01 ,pp. : 425-430

Spandidos Publications

Access to resources Recommend Favorite

Silencing of survivin by YM155 induces apoptosis and growth arrest in hepatocellular carcinoma cells

Oncology Letters, Vol. 10, Iss. 3, 2015-01 ,pp. : 1627-1631

Spandidos Publications

Access to resources Recommend Favorite

Cisplatin in combination with programmed cell death protein 5 increases antitumor activity in prostate cancer cells by promoting apoptosis

Molecular Medicine Reports, Vol. 11, Iss. 6, 2015-01 ,pp. : 4561-4566

Spandidos Publications

Access to resources Recommend Favorite

Enhanced antitumor activity by the combination of dasatinib and combretastatin A-4 in vitro and in vivo

Oncology Reports, Vol. 29, Iss. 6, 2013-01 ,pp. : 2275-2282

Spandidos Publications

Access to resources Recommend Favorite